AGEROS

House mark for pharmaceuticals for the treatment of mitochondrial diseases, disorders, and conditions, cardiovascular diseases, disorders, and conditions, musculoskeletal diseases, disorders, and conditions, neurodegenerative diseases, disorders, and conditions, metabolic diseases, disorders, and conditions, renal diseases, disorders, and conditions, ophthalmological diseases, disorders, and conditions, and diseases, disorders, and conditions related to aging

Research and development of pharmaceuticals in the fields of mitochondrial diseases, disorders, and conditions, cardiovascular diseases, disorders, and conditions, musculoskeletal diseases, disorders, and conditions, neurodegenerative diseases, disorders, and conditions, oncological diseases, metabolic diseases, disorders, and conditions, renal diseases, disorders, and conditions, ophthalmological diseases, disorders, and conditions, and diseases, disorders, and conditions related to aging